FORTRESS BIOTECH INC (FBIO) Stock Balance Sheet
NASDAQ:FBIO • US34960Q3074
Current stock price
2.27 USD
-0.06 (-2.58%)
At close:
2.33 USD
+0.06 (+2.64%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 79.38M | 57.26M | 80.93M | 178.30M | 305.70M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 29.94M | 10.40M | 15.39M | 28.30M | 23.80M | |||
| Inventories | 9.62M | 14.43M | 10.21M | 14.20M | 9.90M | |||
| Other Current Assets | 4.89M | 8.28M | 10.50M | 9.70M | 7.10M | |||
| Total Current Assets | 123.84M | 90.37M | 117.02M | 230.40M | 346.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.82M | 17.12M | 23.50M | 33.00M | 34.10M | |||
| Investments And Advances | 17.66M | N/A | N/A | N/A | 0.00 | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 27.61M | 31.86M | 20.29M | 27.20M | 12.60M | |||
| Other Non-Current Assets | 1.62M | 4.87M | 6.72M | 3.70M | 3.40M | |||
| Total Non-Current Assets | 61.71M | 53.85M | 50.50M | 63.90M | 50.00M | |||
| TOTAL ASSETS | 185.55M | 144.22M | 167.53M | 294.30M | 396.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 625.00K | 3.00M | 7.20M | 4.50M | |||
| Accrued Expenses | 33.89M | 19.94M | 23.06M | 22.80M | 25.30M | |||
| Accounts Payable | 15.36M | 48.18M | 53.03M | 77.10M | 67.40M | |||
| Other Current Liabilities | 492.00K | 2.65M | 5.82M | 20.60M | 3.80M | |||
| Total Current Liabilities | 49.74M | 71.40M | 84.91M | 127.70M | 101.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 59.50M | 57.96M | 60.86M | 93.10M | 46.60M | |||
| Other Non-Current Liabilities | 14.12M | 16.51M | 20.18M | 23.40M | 23.00M | |||
| Total Non-Current Liabilities | 85.93M | 50.09M | 60.07M | 124.90M | 186.80M | |||
| TOTAL LIABILITIES | 135.68M | 121.49M | 144.98M | 252.60M | 287.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -734.05M | -740.87M | -694.87M | -634.20M | -547.50M | |||
| Additional Paid In Capital | 783.89M | 763.57M | 717.40M | 675.80M | 656.00M | |||
| Minority Interest | 12.31M | -24.38M | -20.96M | 8.30M | 117.20M | |||
| Common Shares | 34.00K | 31.00K | 18.00K | 100.00K | 100.00K | |||
| Shares Outstanding | 31.36M | 27.91M | 15.09M | 7.40M | 6.80M | |||
| Tangible Book Value per Share | 0.71 | -0.33 | 0.15 | 1.96 | 14.13 | |||
| Total Shareholders' Equity | 49.87M | 22.74M | 22.54M | 41.70M | 108.70M | |||
| TOTAL LIABILITIES AND EQUITY | 185.55M | 144.22M | 167.53M | 294.30M | 396.50M | |||
| Statistics | ||||||||
| Debt/Equity | 1.19 | 2.55 | 2.70 | 2.23 | 0.43 | |||
| Current Ratio | 2.49 | 1.27 | 1.38 | 1.80 | 3.43 | |||
| Return On Assets (ROA) | -1.01% | -38.75% | -40.99% | -29.42% | -16.32% | |||
| Return On Equity (ROE) | -3.77% | -245.81% | -304.60% | -207.63% | -59.52% | |||
All data in USD , ROIC based on taxRate of 0.21